What You'll Learn:

• An update on the newly approved kidney allocation policy
• How to address implementation within your own transplant program
• What will this mean for patients currently on the list and those being currently evaluated

What you'll learn:

• Describe the common targets for direct acting antiviral therapy for HCV
• Understand current side effects and cure rates to therapy for HCV in liver transplant patients
• Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

• A brief overview of risks of living kidney donation known to date
• Discussion of the study design, methods and statistics in the manuscripts
• Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information

Explore the relevance of HLA testing before and after transplant in solid organ transplantation.

At the end of this webinar, participants will be able to:

• Understand the enhanced methods of HLA typing and antibody detection now available before transplant
• Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
• Appreciate the limitations of HLA testing and the importance of context in interpretation

Transplant clinicians strive to prevent infection, and vaccination provides an opportunity to expand this effort. The current recommendations for vaccination, innovative research, and opportunity for advancing these efforts will be discussed.

Objectives:

• Explore current pre- and post-transplant vaccination recommendations for pediatric and adult transplant candidates/recipients.
• Appraise recent vaccination studies in transplantation with a focus on live-vaccines and more recently approved vaccinations.
• Identify new opportunities for vaccination in transplantation that are emerging.

Explore the diagnosis and treatment strategies, including the role of desensitization, in lung and heart transplantation. Discuss challenges and avenues for further research and investigation.

• Describe how to diagnose antibody-mediated rejection in lung and heart transplant recipients.
• Evaluate and review the desensitization strategies currently used in lung and heart transplant candidates and recipients.
• Summarize the different treatment approaches for treatment of antibody-mediated rejection.

The debate over the appropriateness of combined liver and kidney transplants was stoked by the introduction of the MELD system and continues today as the waiting list for kidney alone candidates continues to grow. This education session will feature a review of the current data and experience with combined liver and kidney transplantation and will explore the controversial topics of when to allocate a kidney to candidates with liver failure and acute kidney injury.

Objectives:

• Describe the current policies at UNOS regarding simultaneous liver-kidney allocation
• Explain data related to outcomes for liver transplant candidates with kidney injury
• Summarize arguments and ethics surrounding the development of new allocation policies for simultaneous liver-kidney transplantation